Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis
UMass Chan Affiliations
Department of Medicine, Division of RheumatologyDocument Type
Journal ArticlePublication Date
2010-06-15Keywords
TNF-α inhibitorsankylosing spondylitis
golimumab
psoriatic arthritis
rheumatoid arthritis
Musculoskeletal Diseases
Rheumatology
Skin and Connective Tissue Diseases